GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...

While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...

Pancreatic cancer mostly develops deep in the abdomen and shows few symptoms in the beginning. Still, some early warning ...

GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the study ...

Study finds GLP-1 drugs may reduce risk of more than a dozen cancers, offering hope in Louisiana where obesity-related cancer ...

FOR well over a million Brits, fat jabs have been a game-changer – ending ‘food noise’, dulling hunger pangs and helping the ...

The problem is becoming more common as the medications are increasingly used by people seeking cosmetic weight loss and who ...

Higher body mass index (BMI) after diagnosis is linked to better survival outcomes in patients with localized renal cell ...

The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...

New research suggests that people taking GLP-1 therapy are less likely to die from colorectal cancer. Ozempic, the cancer ...

GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study ...

Early colon cancer signs like persistent bowel changes, pencil-thin stools, unexplained weight loss, and fatigue are often ...